Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC AZD1390,5mg CAS# 2089288-03-7
SDP

Supplier:  Apexbio Technology LLC B83285

Encompass_Preferred

AZD1390 is a potent and selective inhibitor of ataxia telangiectasia mutant (ATM) kinase, with IC50 value of 0.78 nM in cells [1]. ATM, a serine/threonine protein kinase from the phosphatidylinositol 3-kinase-related kinase family of protein kinases, plays an important role in the cellular DNA damage response signaling activated by DNA double-strand breaks. Activated ATM promotes DNA repair and S/G1-cell cycle checkpoints to prevent premature mitosis, maintain genomic integrity, and promote appropriate cell survival or death pathways [1]. In LN18 GBM cells, AZD1390 at a concentration of 3 nM produced a strong inhibition of ATM. In NCI-H2228 cells, AZD1390 (10 nM) combined with radiation induced G2 cell cycle phase accumulation, micronuclei, and apoptosis. Furthermore, AZD1390 at 10 nM radiosensitized glioma and lung cancer cell lines, with p53 mutant glioma cells generally being more radiosensitized than the wild type [2].  Other sizes are also available. Please inqury us for quote.

Catalog No. 50-224-0073


May include imposed supplier surcharges.
Only null left
Add to Cart
This item is not returnable. View return policy

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.